IQV
Price
$145.55
Change
+$2.33 (+1.63%)
Updated
Apr 11 closing price
Capitalization
45.3B
18 days until earnings call
OPK
Price
$1.42
Change
+$0.05 (+3.68%)
Updated
Apr 11 closing price
Capitalization
920.03M
31 days until earnings call
Ad is loading...

IQV vs OPK

Header iconIQV vs OPK Comparison
Open Charts IQV vs OPKBanner chart's image
IQVIA Holdings
Price$145.55
Change+$2.33 (+1.63%)
Volume$2.6M
Capitalization45.3B
OPKO Health
Price$1.42
Change+$0.05 (+3.68%)
Volume$2.67M
Capitalization920.03M
IQV vs OPK Comparison Chart
Loading...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IQV vs. OPK commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Hold and OPK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (IQV: $145.55 vs. OPK: $1.41)
Brand notoriety: IQV: Notable vs. OPK: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IQV: 145% vs. OPK: 47%
Market capitalization -- IQV: $45.3B vs. OPK: $920.03M
IQV [@Medical Specialties] is valued at $45.3B. OPK’s [@Medical Specialties] market capitalization is $920.03M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 0 FA rating(s) are green whileOPK’s FA Score has 0 green FA rating(s).

  • IQV’s FA Score: 0 green, 5 red.
  • OPK’s FA Score: 0 green, 5 red.
According to our system of comparison, IQV is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while OPK’s TA Score has 4 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 4 bearish.
  • OPK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IQV is a better buy in the short-term than OPK.

Price Growth

IQV (@Medical Specialties) experienced а -5.93% price change this week, while OPK (@Medical Specialties) price change was -8.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.20%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

IQV is expected to report earnings on Jul 29, 2025.

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.20% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) has a higher market cap than OPK($920M). IQV has higher P/E ratio than OPK: IQV (34.14) vs OPK (26.11). OPK YTD gains are higher at: -3.742 vs. IQV (-25.933). IQV has higher annual earnings (EBITDA): 3.26B vs. OPK (-65.52M). IQV has more cash in the bank: 1.5B vs. OPK (95.9M). OPK has less debt than IQV: OPK (327M) vs IQV (13.9B). IQV has higher revenues than OPK: IQV (15B) vs OPK (863M).
IQVOPKIQV / OPK
Capitalization45.3B920M4,924%
EBITDA3.26B-65.52M-4,970%
Gain YTD-25.933-3.742693%
P/E Ratio34.1426.11131%
Revenue15B863M1,738%
Total Cash1.5B95.9M1,560%
Total Debt13.9B327M4,251%
FUNDAMENTALS RATINGS
IQV vs OPK: Fundamental Ratings
IQV
OPK
OUTLOOK RATING
1..100
6152
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
4190
PRICE GROWTH RATING
1..100
6562
P/E GROWTH RATING
1..100
8697
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPK's Valuation (68) in the Biotechnology industry is in the same range as IQV (69) in the Servicestothe Health Industry industry. This means that OPK’s stock grew similarly to IQV’s over the last 12 months.

IQV's Profit vs Risk Rating (64) in the Servicestothe Health Industry industry is somewhat better than the same rating for OPK (100) in the Biotechnology industry. This means that IQV’s stock grew somewhat faster than OPK’s over the last 12 months.

IQV's SMR Rating (41) in the Servicestothe Health Industry industry is somewhat better than the same rating for OPK (90) in the Biotechnology industry. This means that IQV’s stock grew somewhat faster than OPK’s over the last 12 months.

OPK's Price Growth Rating (62) in the Biotechnology industry is in the same range as IQV (65) in the Servicestothe Health Industry industry. This means that OPK’s stock grew similarly to IQV’s over the last 12 months.

IQV's P/E Growth Rating (86) in the Servicestothe Health Industry industry is in the same range as OPK (97) in the Biotechnology industry. This means that IQV’s stock grew similarly to OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQVOPK
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 20 days ago
62%
Bullish Trend 27 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFVLX29.83N/A
N/A
Commerce Value
MWEHX40.65N/A
N/A
MFS Global Equity R3
MGQAX15.61N/A
N/A
Morgan Stanley Inst Global Stars A
TRTIX17.69N/A
N/A
T. Rowe Price International Value Eq I
GSJPX30.55N/A
N/A
Goldman Sachs Technology Opps P

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+1.63%
CRL - IQV
73%
Closely correlated
-0.20%
ICLR - IQV
69%
Closely correlated
+0.98%
TMO - IQV
67%
Closely correlated
+2.51%
A - IQV
66%
Loosely correlated
+2.76%
RVTY - IQV
66%
Loosely correlated
+1.98%
More